Controlling genital chlamydial infectionBMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7079.516a (Published 15 February 1997) Cite this as: BMJ 1997;314:516
Figures are underestimates because men are not tested
- M J Bolam, Clinical assistant in genitourinary medicinea
- a Greenwich District Hospital, London SE10 9HE
- b Department of Public Health, Leicestershire Health, Leicester LE5 4QF
- c Department of Genitourinary Medicine, Leicester Royal Infirmary, Leicester LE1 5WW
Editor—Anne M Johnson and colleagues are right to say in their editorial on controlling genital chlamydial infection that screening, diagnosis, and treatment remain inconsistent.1 Returns from genitourinary medicine clinics cannot give any useful estimate of the true incidence of chlamydial infection while so many clinics do not routinely screen male patients; the figure of 39 000 treated cases in England and Wales in 1995 must be far short of the true figure.
In some clinics screening for chlamydia is rationed because of cost. These clinics usually accept that men will not be given a chlamydia test because they are, in any case, going to receive antibiotic treatment effective against chlamydia. This includes men whose symptoms and signs, together with the presence of pus …